Autoren

Matthew Royle, Ph.D.

Partner

Read More

Dr. Manja Epping

Partnerin

Read More

Evelyne Friedel

Partner

Read More
Autoren

Matthew Royle, Ph.D.

Partner

Read More

Dr. Manja Epping

Partnerin

Read More

Evelyne Friedel

Partner

Read More

30. September 2019 | 55:41

Biosimilars – Clearing the way for launch

In the third webinar of our series exploring the key differences between US and Europe biosimilars litigation and regulation, our experts discuss strategies for clearing the way to an early launch of a biosimilar.

Many of the top-selling drugs worldwide are biologics, and several companies are seeking to produce biosimilars to compete in these lucrative markets.

There are an increasing number of biologics reaching the end of their primary patent protection, and these companies must navigate the landscape of secondary patent protection in order to launch their biosimilars.

The strategies for doing so differ in the US and Europe, and there are different tools available.

Session 3 of this series focuses on strategic options for securing an early launch of a biosimilar, in particular:

  • devising a strategy to clear the way in Europe
  • so-called Arrow declarations may be available to provide a defence to any pending patent applications
  • Devising a strategy to clear the way in the US.
Call To Action Arrow Image

Newsletter-Anmeldung

Wählen Sie aus unserem Angebot Ihre Interessen aus!

Jetzt abonnieren
Jetzt abonnieren

Related Insights

Life Sciences & Gesundheitswesen

Biologics and biosimilars litigation update

25. November 2020
Quick read

von Matthew Royle, Ph.D. und Dr. Nora E. Wessendorf, LL.M. (Washington)

Klicken Sie hier für Details
Life Sciences & Gesundheitswesen

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

27. Juli 2020
QUICK READ

von mehreren Autoren

Klicken Sie hier für Details
Life Sciences & Gesundheitswesen

Everything biologic and biosimilar in-house counsel need to know about COVID-19

29. April 2020

von mehreren Autoren

Klicken Sie hier für Details

Events

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.